Pre-Filled Syringes East Coast
April 26 - 27, 2017 - Boston UK

SMi Group

tarri@smi-online.co.uk
Phone: 2078276000
Fax: 2078276000

Building on the success of previous sell-out shows, SMi Group is delighted to announce the return of the 4th annual conference and exhibition: Pre-Filled Syringes - East Coast, taking place on April 26th – 27th 2017 in Boston, Massachusetts, USA. With an increase in chronic diseases, high competition between market providers, and a growing demand for ready-to-administer (RTA) syringes, the dynamic pre-filled syringes market has in recent years, witnessed a huge surge in investment. However, navigating through the PFS industry in areas such as regulation, manufacturing, safety assessment and combination products, can present complex challenges to success. Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS market professionals, providing a unique platform to discuss the latest innovations and developments in pre-filled syringes; as well as hone in on industry challenges and regulatory compliance. The notable speaker line-up will include: • Li-Chun Tsou, Global Device Technical Director, AstraZeneca • Ronald Iacocca, Research Fellow, Delivery and Device, R&D, Eli Lilly • Edmond Israelski, Director Human Factors, AbbVie • Antony Trupiano, Head of Combination Product Development, Shire • Sudeshna Dutta Ray, Senior Engineer Advanced Device Technology, Amgen • Stephen Barat, Executive Director, Non-Clinical and Translational Sciences - Safety Assessment and Bioanalysis, Allergan • Tiffnay McIntire, Human Factors Engineer, Eli Lilly • Hemal Mehta, Manager, Global CMC-RA, Medical Devices and Combination Products, Janssen R&D • Phillip Green, Executive Director, Merck • Michael Selzer, Manager, Combination Products Engineering, Regeneron • Mike Price, Senior Engineer, Biogen Reasons to attend: • Analyse and forecast market trends for prefills • Explore safety assessments, leachable and the PQRI • Receive guidance on successful change controls for design changes and device changes • Highlight the innovative solutions that wearable devices provide in overcoming the challenges presented by biologic drugs • Navigate through human factor regulations For more information or to register, visit www.pfsamericas.com

More Information